Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation - Archive ouverte HAL
Journal Articles American Journal of Transplantation Year : 2019

Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation

Romain Kessler
  • Function : Author
Olivier Brugière
  • Function : Author
Jean François Mornex
  • Function : Author
Romain Guillemain
  • Function : Author
Johanna Claustre
  • Function : Author

Abstract

Bronchiolitis obliterans syndrome is the main limitation for long-term survival after lung transplantation. Some specific B cell populations are associated with long-term graft acceptance. We aimed to monitor the B cell profile during early development of bronchiolitis obliterans syndrome after lung transplantation. The B cell longitudinal profile was analyzed in peripheral blood mononuclear cells from patients with bronchiolitis obliterans syndrome and patients who remained stable over 3 years of follow-up. CD24(hi)CD38(hi) transitional B cells were increased in stable patients only, and reached a peak 24 months after transplantation, whereas they remained unchanged in patients who developed a bronchiolitis obliterans syndrome. These CD24(hi)CD38(hi) transitional B cells specifically secrete IL-10 and express CD9. Thus, patients with a total CD9(+) B cell frequency below 6.6% displayed significantly higher incidence of bronchiolitis obliterans syndrome (AUC = 0.836, PPV = 0.75, NPV = 1). These data are the first to associate IL-10-secreting CD24(hi)CD38(hi) transitional B cells expressing CD9 with better allograft outcome in lung transplant recipients. CD9-expressing B cells appear as a contributor to a favorable environment essential for the maintenance of long-term stable graft function and as a new predictive biomarker of bronchiolitis obliterans syndrome-free survival.
Fichier principal
Vignette du fichier
1-s2.0-S160061352209308X-main.pdf (890.27 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-04275700 , version 1 (24-09-2024)

Licence

Identifiers

Cite

Carole Brosseau, Richard Danger, Maxim Durand, Eugénie Durand, Aurore Foureau, et al.. Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation. American Journal of Transplantation, 2019, 19 (11), pp.3162-3175. ⟨10.1111/ajt.15532⟩. ⟨hal-04275700⟩
74 View
8 Download

Altmetric

Share

More